Abiopharma

🔍 Drafts William Arnold (Executive)

Company: M-tron Industries, Inc. (MPTI)

Report Date: 2026-04-13

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-13 | Code: H | shares_owned_after: 14,177.00
• Sold 720 shares of Subscription Rights (right to purchase) at $59.0 per share (Derivative)
  Date: 2026-04-06 | Code: S | Expires: 2026-04-20 | Exercise: 2026-03-31 | equity_swap_involved: 0 | shares_owned_after: 8,149.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,521 shares of Subscription Rights (right to purchase) at $59.0 per share (Derivative)
  Date: 2026-04-13 | Code: S | Expires: 2026-04-20 | Exercise: 2026-03-31 | equity_swap_involved: 0 | shares_owned_after: 540.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 108 shares of Subscription Rights (right to purchase) at $59.0 per share (Derivative)
  Date: 2026-04-14 | Code: S | Expires: 2026-04-20 | Exercise: 2026-03-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
• Holds 12,500 shares of Stock Option (right to buy) at $40.32 per share (Derivative)
  Date: 2026-04-13 | Code: H | Expires: 2030-04-04 | Exercise: 2026-04-04 | shares_owned_after: 12,500.00 | Footnotes: F1

Footnotes:

• F1: Stock options of the Issuer vesting as follows: 30% on 4/4/2026, 30% on 4/4/2027, and 40% on 4/4/2028.
• F2: On March 30, 2026, holders of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), received one subscription right (the "Rights") for each share of Common Stock held by such holder as of March 27, 2026. When exercisable, five (5) Rights will entitle their holder to purchase one share of Common Stock at an exercise price of $59.00 per share.